-
News | 2019.10.02
National Health Laboratory Project launched
Yangon, 27 September 2019French Development Agency (AFD), European Union (EU) and Ministry of Health and Sports (MoHS) to collaborate on improving Myanmar’s ability to diagnose and manage infectious diseasesIn the presence of the French Ambassador Christian Lechervy, EU Ambassador Kristian Schmidt, and the Permanent Secretary of the Ministry of Health and Sports, Prof. Dr. Thet Khine Win, the...
-
News | 2019.10.02
Lassa fever: vaccine set to be trialed
There is currently no vaccine for the Lassa arenavirus, which causes Lassa fever. This hemorrhagic fever, endemic in West Africa, infects up to 300,000 people each year. Given the urgency of the situation, scientists in the Biology of Viral Emerging Infections Unit and the Viral Genomics and Vaccination Unit at the Institut Pasteur evaluated the efficacy of several vaccine candidates. Following...
-
News | 2019.09.24
S3ODEON 2019 – Institut Pasteur partner to an event linking science and society
On Saturday October 5, the 2019 edition of S3ODEON will be hosted at the Odéon theater. This annual public event, partnered by the Institut Pasteur, features short speeches on three major topics: science, health and society. This year, Guillaume Dumas, a scientist in the Institut Pasteur’s Human Genetics and Cognitive Functions Unit, will be presenting his research topic.S3ODEON is based on an...
-
News | 2019.09.27
Rabies: a shorter, cheaper vaccination schedule following a suspected rabid dog bite
A study by teams from the Institut Pasteur du Cambodge and the Institut Pasteur in Paris confirms the efficacy of the new post-exposure rabies vaccination schedule developed in the Institut Pasteur International Network and adopted by the World Health Organization (WHO). Since 2018, WHO has recommended post-exposure vaccination for rabies, immediately after a bite by a suspected rabid...
-
News | 2019.10.10
Economist Jim O’Neill, and other experts, discuss Antimicrobial Resistance at the Institut Pasteur
On September 26, 2019, as part of its Antimicrobial Resistance (AMR) initiative the Institut Pasteur hosted a round table discussion on the economic context of the fight against AMR. Lord Jim O’Neill, economist and author of the famous O’Neill report, a publication instrumental in putting AMR on the political landscape, was a key contributor, along with other experts representing public health,...
-
Document de presse | 2019.10.03
Dysentery: Shigella, bacteria with adaptation to respiration
Bacillary dysentery caused by the intestinal bacteria Shigella is a major health problem in tropical regions and developing countries. Complications from this infection lead to several hundred thousand deaths a year, primarily among infants. Researchers from Inserm and the Institut Pasteur have studied the mechanisms of Shigella virulence. They found that these bacteria are not only able to...
-
News | 2019.10.16
How the influenza virus achieves efficient viral RNA replication
New insights on how subunits of the influenza virus polymerase co-evolve to ensure efficient viral RNA replication are provided by a study published October 3 in the PLOS Pathogens journal, by researchers from the Institut Pasteur and the CNRS (French National Center for Scientific Research). As the authors note, the findings could lead to novel strategies for antiviral drug development.Because...
-
News | 2019.10.15
Yersinia – a novel genomic tool for identifying strains
The Yersinia genus covers a vast range of bacteria that are distinguished by criteria such as whether or not they are able to cause disease (their pathogenicity). For instance, Yersinia pestis causes plague, while the bacteria Yersinia enterocolitica and Yersinia pseudotuberculosis are responsible for bowel diseases. Researchers at the Institut Pasteur have developed a new genomic analysis method...
-
News | 2019.10.11
EDF Group Foundation supports the Institut Pasteur and the DIVA project
During its current term, the EDF Group Foundation has chosen to support an Institut Pasteur team working on the DIVA project. This project aims to revolutionize the analysis and visualization of all medical imaging data. The aim is to develop a novel software platform that integrates data from medical imaging or microscopy to enable physicians and scientists to process and visualize images. The...
-
Article | 2019.10.21
Bordet Class (2019-2022)
Ph.D. StudentUndergraduate StudiesLaboratoryThesis AdvisorLab HeadDoctoral SchoolPh.D. ProjectPPU - studentsAICHER, Sophie-MarieImperial College London, London, United Kingdom Viral Genomics and vaccinationNolwenn JouvenetFrédéric TangyBioSPC ED 562 Human and avian antiviral response to zoonotic RNA virusesCOSTREIE, Maria-MirunaUniversity of Glasgow, Glasgow, ScotlandDynamic...
